Sensus Healthcare
SRTS
56 hedge funds and large institutions have $39.1M invested in Sensus Healthcare in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 6 closing their positions.
264% more call options, than puts
Call options by funds: $1.77M | Put options by funds: $488K
60% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 15
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
3.91% more ownership
Funds ownership: 26.53% → 30.44% (+3.9%)
4% more funds holding
Funds holding: 54 → 56 (+2)
13% less capital invested
Capital invested by funds: $44.7M → $39.1M (-$5.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.15M |
| 2 |
Morgan Stanley
New York
|
+$1.9M |
| 3 |
Millennium Management
New York
|
+$1.05M |
| 4 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
+$881K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$868K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$829K |
| 2 |
BlackRock
New York
|
-$604K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$538K |
| 4 |
EGM
Engineers Gate Manager
New York
|
-$363K |
| 5 |
Two Sigma Investments
New York
|
-$318K |
SRTS Hedge Fund Activity: Q2 2022 in Review
56 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q2 2022, worth a combined $39.1M — down 13% from $44.7M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new SRTS positions and 6 closed out — a net gain of 3 holders — while 24 added to existing stakes and 15 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $2.15M. The largest seller was Renaissance Technologies, cutting an estimated $829K.
- 56 institutional investors held Sensus Healthcare (SRTS) as of Q2 2022, up from 54 in Q1 2022.
- Funds reported $39.1M of Sensus Healthcare stock for Q2 2022, down 13% quarter-over-quarter.
- 9 funds opened new Sensus Healthcare positions in Q2 2022 and 6 closed out, a net change of +3 holders.
- The largest Sensus Healthcare buyer in Q2 2022 was Acadian Asset Management, an estimated $2.15M added.
- The largest Sensus Healthcare seller in Q2 2022 was Renaissance Technologies, an estimated $829K sold.
Based on aggregated 13F filings for Q2 2022.